Table 2

Kinetic parameters of acenocoumarol and warfarin hydroxylations catalyzed by recombinant human cytochrome P450 enzymes

P450SubstrateMetaboliteKmVmaxVmax/Km
μM pmol · min−1 · nmol−1CYP μl · min−1 · nmol−1 CYP
CYP2C9(R)-AC2-a 6-OH9.2  ± 0.640.5  ± 7.43.7  ± 2.0
7-OH12.0  ± 0.759.0  ± 2.54.2  ± 1.2
8-OH10.7  ± 2.06.5  ± 1.00.7  ± 0.2
(S)-AC6-OH2.6  ± 0.05350  ± 22137  ± 12
7-OH2.9  ± 0.02380  ± 18129  ± 12
8-OH3.0  ± 0.0738  ± 811.7  ± 2.2
(S)-W4′-OH7.1  ± 1.113.8  ± 2.22.2  ± 2.0
6-OH9.9  ± 0.7105  ± 99.9  ± 1.8
7-OH9.9  ± 0.6190  ± 1218.7  ± 3.2
CYP2C19(R)-AC6-OH76  ± 1079  ± 12.21.1  ± 0.6
7-OH72  ± 6.3113  ± 91.8  ± 0.4
8-OH97  ± 1485  ± 90.7  ± 0.4
(R)-W6-OH>200100  ± 16<0.5
7-OH>20060  ± 9<0.5
8-OH>20062  ± 10<0.5

Enzyme kinetics were only established for enzyme-substrate combinations as shown. Other combinations were to low in activity (see Fig. 1). Data are the mean ± S.D. of two separate incubations in triplicate. See Materials and Methods for details.

  • 2-a  AC, acenocoumarol; W, warfarin.